1. Home
  2. GNS vs ADVM Comparison

GNS vs ADVM Comparison

Compare GNS & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNS
  • ADVM
  • Stock Information
  • Founded
  • GNS 2002
  • ADVM 2006
  • Country
  • GNS Singapore
  • ADVM United States
  • Employees
  • GNS N/A
  • ADVM N/A
  • Industry
  • GNS Other Consumer Services
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GNS Real Estate
  • ADVM Health Care
  • Exchange
  • GNS Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • GNS 81.8M
  • ADVM 94.6M
  • IPO Year
  • GNS 2022
  • ADVM 2014
  • Fundamental
  • Price
  • GNS $0.88
  • ADVM $4.20
  • Analyst Decision
  • GNS
  • ADVM Strong Buy
  • Analyst Count
  • GNS 0
  • ADVM 4
  • Target Price
  • GNS N/A
  • ADVM $19.75
  • AVG Volume (30 Days)
  • GNS 1.6M
  • ADVM 281.1K
  • Earning Date
  • GNS 09-23-2025
  • ADVM 11-07-2025
  • Dividend Yield
  • GNS N/A
  • ADVM N/A
  • EPS Growth
  • GNS N/A
  • ADVM N/A
  • EPS
  • GNS N/A
  • ADVM N/A
  • Revenue
  • GNS $5,749,894.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • GNS $62.23
  • ADVM $1,449.40
  • Revenue Next Year
  • GNS $69.63
  • ADVM N/A
  • P/E Ratio
  • GNS N/A
  • ADVM N/A
  • Revenue Growth
  • GNS N/A
  • ADVM N/A
  • 52 Week Low
  • GNS $0.21
  • ADVM $1.78
  • 52 Week High
  • GNS $1.92
  • ADVM $8.33
  • Technical
  • Relative Strength Index (RSI)
  • GNS 47.83
  • ADVM 47.67
  • Support Level
  • GNS $0.79
  • ADVM $4.11
  • Resistance Level
  • GNS $0.90
  • ADVM $4.53
  • Average True Range (ATR)
  • GNS 0.08
  • ADVM 0.44
  • MACD
  • GNS -0.00
  • ADVM -0.13
  • Stochastic Oscillator
  • GNS 45.45
  • ADVM 4.73

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education, which involves entrepreneur education, management consultancy, and business development tools; and Campus, consisting of resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America. The company derives maximum revenue from Europe/Middle East/Africa.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: